Table 2.
Secondary analysis of primary outcome over the course of the study
Time, mo | Control | Intervention | P Value |
---|---|---|---|
6 | −0.12 (−0.54 to 0.29) | −0.18 (−0.25 to 0.45) | 0.82 |
12 | 0.19 (−0.37 to 0.75) | 0.10 (−0.19 to 0.59) | 0.79 |
18 | −0.55 (−1.10 to −0.01) | −1.02 (−1.38 to −0.66) | 0.16 |
24 | −2.00 (−4.04 to 0.05) | −2.29 (−3.89 to −0.69) | 0.59 |
30 | −1.17 (−1.87 to −0.47) | −1.43 (−1.43 to −0.87) | 0.56 |
36 | −1.43 (−2.07 to −0.80) | −1.47 (−1.98 to −0.96) | 0.93 |
42 | −2.00 (−3.95 to 0.92) | −2.29 (−3.89 to −0.69) | 0.82 |
Values represent mean change in eGFR in milliliters per minute per 1.73 m2 (95% confidence interval), and a negative value represents a fall in eGFR.